Olivia Putri Chairunnisa, Mia Audina, and Irawati , Trans., “Which Anti-VEGF Therapy (Ranibizumab, Bevacizumab, or Aflibercept) Demonstrates The Most Cost-Effective Outcomes For Treating Age-Related Macular Degeneration ? : A Systematic Review”, the. Indonesian. j. gen. med., vol. 12, no. 3, pp. 1–48, May 2025, doi: 10.70070/vbsedq58.